Abstract
Background: Stereotactic core needle breast biopsy (SCNBB) is a minimally invasive technique used to sample nonpalpable mammographic abnormalities. The optimal management of atypical ductal hyperplasia (ADH) diagnosed by SCNBB is unknown. We hypothesized that ADH diagnosed by SCNBB should be evaluated by excisional breast biopsy (EBB) because of the risk of identifying carcinoma in association with ADH that would be missed if a diagnostic sampling technique alone was utilized.
Methods: To test this hypothesis, a prospective diagnostic protocol was created which called for SCNBB instead of EBB for patients with mammographic abnormalities considered suspicious for malignancy. If ADH was noted on histologic evaluation of the cores, patients were advised to undergo an EBB.
Results: A review of the initial 900 patients evaluated by SCNBB yielded 39 patients (4.3%) with ADH detected by SCNBB. Thirty-six of these 39 patients agreed to proceed with EBB: 19 patients demonstrated benign findings including atypical ductal hyperplasia, 13 patients demonstrated non-invasive ductal carcinoma, and 4 patients had evidence of invasive carcinoma.
Conclusions: A 47% rate of detecting noninvasive or invasive breast carcinoma supports the hypothesis that ADH detected by a sampling technique, such as SCNBB, should be managed by EBB.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
Ciatto S, Cecchini S, Iossa A, Grazzini G, Bravetti P, Rosselli del Turco M, Cataliotti L, et al. Prognosis of nonpalpable infiltrating carcinoma of the breast.Surg Gynecol Obstet 1990;170:61–4.
Marrujo G, Jolly PG, Hall MH. Nonpalpable breast cancer: needle-localized biopsy for diagnosis and consideration for treatment.Am J Surg 1986;151:599–602.
Schmidt RA. Stereotactic breast biopsy.CA Cancer J Clin 1994;44:172–91.
Choucair RJ, Holcomb MB, Matthews R, Hughes TG. Biopsy of nonpalpable breast lesions.Am J Surg 1988;156:453–6.
Thompson WR, Bowen JR, Dorman BA, Pricolo VE, Shahinian TK, Soderberg CH. Mammographic localization and biopsy of nonpalpable breast lesions: a 5-year study.Arch Surg 1991;126:730–4.
Schwartz GF, Feig SA, Patchefsky AS. Significance and staging of nonpalpable carcinomas of the breast.Surg Gynecol Obstet 1988;166:6–10.
Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast: a long-term follow-up study.Cancer 1985;55:2698–708.
Page DL, Anderson TJ.Diagnostic Histopathology of the Breast. New York: Churchill Livingstone 1987:137–45.
Rosen PP. Proliferative breast disease: an unresolved diagnostic dilemma.Cancer 1993;71:3798–807.
Tavassoli FA.Pathology of the Breast. New York: Elsevier 1992:171–83.
Weidner N. The histologic spectrum of in situ breast lesions: hyperplasia, atypical hyperplasia and carcinoma in situ. American Society of Clinical Pathology Teleconference, Dec. 15, 1995, 11–13.
Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results.Radiology 1993;188:453–5.
Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA Jr. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia.Radiology 1994;193:91–5.
Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesiosn: an indication for surgical biopsy.AJR 1995;164:1111–3.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gadzala, D.E., Cederbom, G.J., Bolton, J.S. et al. Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy. Annals of Surgical Oncology 4, 283–286 (1997). https://doi.org/10.1007/BF02303575
Issue Date:
DOI: https://doi.org/10.1007/BF02303575